EN
Srpski (SR)
Deutsch (DE)
Media
Galleries
31. May 2024.
COMPANY DAY/FAMILY DAY 2024
COMPANY DAY/FAMILY DAY 2024
The Family Day for employees and children was held at Vršac factory to mark the company anniversary. This year, as usual, Hemofarm has honoured its jubilarians, while a voluntary blood donation drive has also been organized in cooperation with the Vojvodina Blood Transfusion Institute. All citizens of Vršac, together with Hemofarm employees with their children, had a unique opportunity to visit STADA EXPO, a multimedia exhibition dedicated to sustainable development. The children were especially delighted with the fun and educational program that Hemofarm prepared for them.
08. December 2023.
Hemofarm Achieves Double-digit Growth in 2023
Hemofarm Achieves Double-digit Growth in 2023
‘In this year, Hemofarm has invested more than 36 million EUR, and additional 100 million EUR have already been envisaged for the forthcoming period. The planned investment will make our company a mega-factory, even globally. This is yet another confirmation of our commitment to the Serbian market and the Western Balkans region’, said Ronald Seeliger, Chief Executive Officer of Hemofarm, expressing big expectations in the coming period.
02. June 2023.
Company day/Family day 2023
Company day/Family day 2023
Family Day for employees and children was organized to celebrate company's 63rd birthday at the Vršac factory. This year, once again Hemofarm celebrated its jubilee certificate holders. A voluntary blood donation campaign was organized as well. Health examinations were also organized for the employees at several medical points inside the factory, and children were especially delighted with fun and educational program that Hemofarm prepared for them.
09. December 2022.
62 years of Hemofarm’s business leadership
62 years of Hemofarm’s business leadership
‘Focusing on growth, innovations, and operational excellence, we keep on developing Hemofarm as a modern and responsible company. Following the roadmap of sustainable development, we continue along a not so well-trodden and simple path, which is nevertheless our absolute priority‘, said Dr Ronald Seeliger, CEO of Hemofarm, adding that Hemofarm has preserved the leadership position in both the market of Serbia, and Bosnia and Herzegovina.
MAIN RX PRODUCTS
Bromazepam
Metformin
Diclofenac
Lorazepam
Bisoprolol
Amoxicillin
Metoprolol
Azithromycin
Enalapril
Propafenone
HEMOFARM OVER-THE-COUNTER DRUGS
Panlax
Snup
Ibumax
Hepathrombin
Pressing
Mycoseb
HEMOFARM A.D.
About Us
Do business with us
STADA Group
+381 13 803 100
svakodobro@hemofarm.com

Compliance Reporting Portal

Terms of conditions
Privacy Notice
Personal Data Processing Notification
©Copyright Hemofarm 2024